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ABSTRACT 1 
Palm oil that has been interesterified to produce a higher proportion of palmitic acid 2 
(16:0) in the sn-2 position reduces postprandial lipemia in young, normolipidemic 3 
men and women, but effects in older subjects with higher fasting triacylglycerol 4 
(TAG) concentrations are unknown. We tested the hypothesis that high-fat meals 5 
rich in interesterified palm olein (IPO) decrease lipemia and alter plasma lipoprotein 6 
fraction composition compared to native palm olein (NPO) in men aged 40-70 y with 7 
fasting TAG concentrations ≥1.2 mmol/L. Postprandial changes in plasma lipids 8 
following meals containing 75 g fat (NPO and IPO) were compared using a 9 
randomized, double-blind crossover design (n=11). Although there were no 10 
significant differences in plasma TAG concentrations between meals over the total 6 11 
h postprandial measurement period, IPO resulted in a decreased plasma TAG 12 
response during the first 4 h of the postprandial period (iAUC 1.65 mmol/L.h, 95% CI 13 
1.01-2.29) compared to NPO (iAUC 2.33 mmol/L.h, 95% CI 1.58-3.07); meal effect P 14 
= 0.024. Chylomicron fraction TAG concentrations at 4-6 h were slightly reduced 15 
following IPO compared to NPO (NPO – IPO mean difference 0.29 mmol/L (95% CI -16 
0.01-0.59), P=0.055). There were no differences in IDL fraction TAG, cholesterol or 17 
apolipoprotein B48 concentrations following IPO compared with NPO. In conclusion, 18 
consuming a meal containing palm olein with a higher proportion of 16:0 in the sn-2 19 
position decreases postprandial lipemia compared to native palm olein during the 20 
early phase of the postprandial period in men with higher than optimal fasting 21 
triacylglycerol concentrations.  22 
KEY WORDS 23 
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ABBREVIATIONS 25 
iAUC  Incremental area under the curve 26 
DVP  Digital volume pulse 27 
IPO  Interesterified palm olein 28 
NEFA  Non-esterified fatty acids 29 
NPO  Native palm olein 30 
TAG  Triacylglycerol 31 
 32 
INTRODUCTION 33 
Following consumption of a fat-containing meal, circulating triacylglycerol (TAG) 34 
concentrations are elevated for up to 8h. As reviewed recently, three recent 35 
prospective studies have confirmed non-fasting TAG concentrations as a strong 36 
predictor of risk of coronary heart disease, and to be more discriminatory than fasting 37 
TAG concentrations [1-4]. Long chain saturated fatty acids such as palmitic acid 38 
(16:0) result in pronounced postprandial lipemia, but the magnitude of the increase in 39 
blood TAG concentrations may depend on the positional composition of the 40 
triacylglycerol [5].  41 
Interesterification is an industrial process to shuffle the position of fatty acids within 42 
the TAG molecule without changing the fatty acid composition of the TAG and is 43 
commonly used by the food industry to produce fats with desirable physical 44 
characteristics. Interesterification of palm oil, which has 16:0 predominantly in the 45 
outer positions of the TAG molecule (sn-1 and sn-3), increases the proportion of 16:0 46 
in the sn-2 position and results in a fat with a higher melting point than native palm 47 
olein (NPO), the latter being liquid at room temperature. The transition within the oils 48 
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and fats industry away from animal fats and trans fatty acids towards interesterified 49 
palm olein (IPO), for use as a solid vegetable fat in bakery products and fat spreads, 50 
has recently prompted a number of scientific investigations into the acute and 51 
chronic health effects of interesterified fats, particularly in relation to their atherogenic 52 
potential [5-10]. Animal studies have demonstrated that consumption of TAG 53 
containing palmitic acid in the sn-2 position promotes atherogenesis to a greater 54 
extent than TAG containing palmitic acid the sn-1 or sn-3 positions [11]. However 55 
chronic human studies have not found an effect of positional composition of palmitic 56 
acid on cholesterol concentrations [12, 13], and there have been no studies to date 57 
investigating longer term markers of atherogenesis. 58 
With regard to postprandial lipemia, the evidence to date is fairly consistent in 59 
showing a decreased postprandial TAG response to IPO compared to NPO during 60 
the initial phase of the postprandial period. Specifically, Yli-Jokipii and colleagues 61 
reported decreased iAUC for plasma TAG concentrations after 55 g/m2 body surface 62 
area IPO compared to NPO in 10 healthy premenopausal women with a mean age 63 
27 y (SD 3) [14], Berry et al. reported decreased plasma TAG concentrations 1-2 h 64 
after 50 g IPO compared to NPO in 20 healthy young men with a mean age of 29 y 65 
(SD 10) [7], and Sanders et al. reported decreased plasma TAG concentrations 1-4 66 
h after 50 g IPO compared to NPO (and high oleic sunflower oil) in 50 healthy young 67 
men and women with a mean aged of 24 y (SD 3) [10]. These three study 68 
populations were all young, with mean fasting TAG from 0.7 to 1.1 mmol/L (SD 0.4 to 69 
0.5), and mean body mass indices of 21 to 23 kg/m2 (SD 2-3). Sanders et al. 70 
concluded that fats that are solid at room temperature with a higher proportion of 71 
palmitic acid at the sn-2 position decrease postprandial lipemia compared with liquid 72 
oils, but that this requires replication in older subjects [10]. The relative postprandial 73 
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lipemic response to IPO in a study population considered to be more “at-risk” of 74 
developing cardiovascular disease has not yet been characterized. Furthermore, 75 
differences in postprandial lipemia that may arise following IPO compared to NPO 76 
may result in compositional differences in circulating lipid fractions which may differ 77 
in their atherogenic potential; for example, a slower rate of increase of TAG-rich 78 
lipoproteins in the early phase of postprandial lipemia may be associated with a 79 
preponderance of TAG-rich lipoproteins and their remnants in the later postprandial 80 
phase. 81 
The present study set out to test the hypothesis that interesterified palm olein, with 82 
an increased proportion of palmitic acid in the sn-2 position, would decrease 83 
postprandial lipemia in middle-aged/older men with higher than optimal fasting 84 
plasma TAG concentrations, but would increase the concentration of TAG in the 85 
lipoprotein fraction rich in TAG-rich lipoprotein remnants (the “IDL” fraction) in the 86 
later postprandial period. The primary outcome measure was incremental area under 87 
the curve (iAUC) for plasma TAG, and secondary outcome measures included TAG 88 
and cholesterol content of lipid subclasses. Other outcome variables included blood 89 
pressure and vascular tone assessed by digital volume pulse (DVP). This is the first 90 
study to date to investigate compositional changes (in TAG, cholesterol and apo-B48 91 
concentrations) in lipid subclasses following a single meal of IPO compared to NPO. 92 
SUBJECTS AND METHODS 93 
Subjects 94 
Ethical approval for the study was obtained from a National Health Service research 95 
ethics committee (NRES Committee London – Dulwich reference 11/LO/0116), and 96 
written informed consent was given by participants. This trial was registered at 97 
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clinicaltrials.gov as NCT01710280. Advertisements and a circular email within King’s 98 
College London were used for recruitment, which was initiated in May 2011 by 99 
research investigators. A participant information sheet was provided to volunteers 100 
who expressed interest. Participants, recruited from King’s College London and the 101 
wider local community, attended the Metabolic Research Unit at the Diabetes & 102 
Nutritional Sciences Division, King’s College London in a fasting state for a 103 
screening appointment which included the measurement of height, weight, waist 104 
circumference, % body fat (by bioelectrical impedance using the TanitaTM Body 105 
Composition Analyser), seated blood pressure, liver function tests, glucose, lipid 106 
profile and haematology. A small remuneration was given for participation in the 107 
postprandial study days. Since the target population was middle-aged/older men with 108 
higher than optimal fasting plasma TAG concentrations, inclusion criteria were: 109 
healthy males aged 40-70 y; non-smoking; and fasting plasma TAG ≥1.2 mmol/L. 110 
The initial aim was to recruit men with fasting plasma TAG ≥1.5 mmol/L but this was 111 
adjusted to ≥1.2 mmol/L due to difficulties recruiting sufficient numbers of volunteers. 112 
Exclusion criteria were as follows: reported medical history of cardiovascular 113 
disease, cancer, liver, kidney or bowel disease; fasting glucose ≥6.1 mmol/L or 114 
uncontrolled type 2 diabetes; presence of gastrointestinal disorder or use of drug 115 
which is likely to alter gastrointestinal motility or nutrient absorption; history of 116 
substance abuse or alcoholism; current self-reported weekly alcohol intake 117 
exceeding 28 units; allergy or intolerance to any component of the test meals; 118 
unwilling to restrict consumption of any source of fish oil for the duration of the study; 119 
weight change of >3 kg in preceding 2 months; body mass index <20 and >35 kg/m2; 120 
fasting blood cholesterol >7.8 mmol/L; and current use of lipid lowering medication. 121 
Sample size calculations were based on 80% power at P = 0.05 to detect a 1.4 122 
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mmol/L.h difference in the iAUC for plasma triacylglycerol concentrations, which 123 
gave a sample size of 11. 124 
Study design 125 
A randomized, double-blind, crossover design was used to compare 2 test meals 126 
that did not differ in appearance, aroma or taste. Each test meal consisted of a 127 
muffin and a milkshake and provided 4.38 MJ (1047 kcal), 14 g protein, 93 g 128 
carbohydrate, and 75 g test fat. The 2 test fats were as follows: native palm olein 129 
(NPO, iodine value 56, Intercontinental Speciality Fats, Selangor, Malaysia) and 130 
interesterified palm olein (IPO, iodine value 56, Wilmar PGEO Edible Oils, Johor, 131 
Malaysia). Both palm olein (PO) fats had a similar fatty acid composition (shown in 132 
Table 1), but the IPO has 45.9 mol% of palmitic acid in the sn-2 position compared 133 
to 9.8 mol% in NPO [5]. The test fats were baked into muffins, labelled with a code A 134 
or B by an independent research technician, and stored frozen until consumed. The 135 
allocation of treatment was blinded from both the investigators and the study 136 
participants.  137 
Subjects were randomly allocated to receive either meal A or B for their first visit by a 138 
single research investigator using a computer randomisation program. The 139 
participants consumed each of the 2 test meals in random order, and each test meal 140 
protocol was separated by at least 1 week. On the day preceding each test meal, 141 
participants were told not to participate in strenuous exercise and to avoid alcohol 142 
and foods high in fat. They were provided with a standardized low-fat meal 143 
(containing <10 g fat) as their evening meal, which they were required to consume 144 
before 2200 h and then to avoid eating or drinking anything except for water. 145 
Participants attended the Metabolic Research Unit between 0800 and 1000 h the 146 
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next day. A cannula was inserted into the forearm antecubital vein, and blood was 147 
collected for baseline analysis. Following a 10 min supine rest, blood pressure and 148 
digital volume pulse measurements were taken in a supine position. The test meal 149 
was consumed within 10 min. Further venous blood samples were collected hourly 150 
until 6 h after the test meal and blood pressure/vascular measurements were made 151 
2, 4 and 6 h after the test meal. Participants had access to water to sip as required 152 
over the 6 h period. After the blood sample at t+3 h, they consumed a light, fat-free 153 
lunch (1.7 MJ consisting of 190 g fat-free yoghurt (<0.1 g fat) and a 120 g banana) 154 
as in previous studies [6, 7, 10, 15].  155 
Methods 156 
Blood samples for total plasma fatty acid composition, plasma TAG fraction fatty acid 157 
composition, plasma NEFA fraction fatty acid composition, plasma TAG, cholesterol, 158 
and NEFA concentrations were collected into EDTA tubes and centrifuged at 1500 x 159 
g for 15 min at 4 °C. Two millilitres plasma from blood samples taken at 4, 5 and 6 h 160 
time points was mixed with 0.77 g potassium bromide and 50 mg sucrose, then 161 
added to Ultraclear ultracentrifuge tubes (Beckman Coulter UK Ltd, catalogue 162 
number 344060), and over-layered with solutions of sodium chloride, potassium 163 
bromide and 100 mg/L EDTA sequentially at densities of 1.225 g/ml (2 ml) and 1.100 164 
g/ml (4 ml), ending with distilled water containing 100 mg/L EDTA (4 ml), according 165 
to the method of Terpstra and colleagues [16, 17]. Ultracentrifugation using a SW40 166 
Ti swinging bucket rotor (Beckman) in a Beckman-Coulter Optima L-90K 167 
ultracentrifuge at 160,070 x g for 42 min at 20 °C with brake to 500 rpm was used to 168 
isolate the chylomicron-rich fraction (aspirating the top 1 ml layer), then the 169 
ultracentrifuge tubes were refilled with distilled water and ultracentrifuged at 230,501 170 
x g for 23 h at 22 °C to obtain the “IDL” layer which contains VLDL, IDL and 171 
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chylomicron remnants. For ease of nomenclature these lipoprotein fractions will be 172 
referred to as the chylomicron fraction (density <1.006 kg/L) and IDL fraction 173 
respectively (density 1.006-1.019 kg/L), although it is recognised that both fractions 174 
will also contain VLDL. Further aliquots of plasma obtained from blood collected 175 
hourly 0-6 h were stored frozen at -80 °C until analysed. Enzymatic assays were 176 
used to determine concentrations of NEFA (WAKO NEFA-HR; WAKO Diagnostics), 177 
cholesterol, and TAG on an ILAB-650 analyser (Instrumentation Laboratories). The 178 
plasma TAG and NEFA fractions were separated by TLC and analyzed by GLC to 179 
determine fatty acid composition [18, 19]. Apolipoprotein B48 concentrations in IDL 180 
fractions were measured using a human apo B48 ELISA kit (Shibayagi Co. 181 
Ltd.,Shibukawa, Japan). Total apolipoprotein B concentrations were measured using 182 
a polyethylene glycol (PEG) enhanced immunoturbidimetric assay (Siemans 183 
Healthcare Diagnostics Ltd, Surrey, UK), however results for this analysis are not 184 
available due to a technical error that occurred during analysis. The intra-assay 185 
coefficients of variation were: NEFA, 6.3%; TAG, 3.4%; cholesterol, 1.0%; and 186 
apolipoprotein B-48, 7.1%. 187 
Blood pressure was measured according to British Hypertension Society guidelines 188 
using an automated upper arm blood pressure monitor, the Omron 705IT (Omron 189 
Healthcare Europe B.V.). The digital volume pulse was obtained by 190 
photoplethysmography (PulseTrace, Micro Medical Ltd., Kent, UK) and used to 191 
calculate stiffness index (DVP-SI, m/s) and reflection index (DVP-RI, %).  192 
Statistical analyses 193 
An incremental AUC (iAUC) was calculated for plasma TAG, NEFA and cholesterol 194 
concentrations and paired t-test carried out to compare meal differences. Repeated 195 
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measures ANOVA was performed (meal and time as within-subject factors) on 196 
change from baseline data for total plasma analytes, or raw data for lipoprotein 197 
fraction data which was only collected at 4-6 h.  A P value <0.05 was considered 198 
statistically significant. 199 
RESULTS 200 
Twenty-five volunteers who met the initial eligibility criteria following a telephone 201 
questionnaire attended screening sessions at the Metabolic Research Unit, Diabetes 202 
& Nutritional Sciences Division, King’s College London, of whom 14 did not meet 203 
inclusion criteria (Figure 1). The screening characteristics of the 11 participants who 204 
completed the study (June-December 2011) are shown in Table 2. 205 
The postprandial changes in plasma TAG and the iAUC after the test meals are 206 
shown in Figure 2. There were no significant differences between meals although 207 
both the treatment effect for plasma TAG changes from baseline (1-6 h) (P = 0.067) 208 
and the iAUC 0-6 h (P = 0.09) showed a trend towards a smaller increase in 209 
postprandial plasma TAG concentrations following IPO compared to NPO. This was 210 
more marked in the early phase of postprandial lipemia and post hoc analysis of the 211 
iAUC from 1-4 h was conducted to determine the early phase postprandial TAG 212 
response. There was a significant difference between meals, with a decrease in Δ 213 
plasma TAG 1-4 h (P = 0.020) and in the iAUC 0-4 h (P = 0.024) observed following 214 
IPO compared to NPO. There were no differences between meals for changes or 215 
iAUC in plasma cholesterol or NEFA concentrations.  216 
The TAG concentration of the chlyomicron fraction (4-6 h) was decreased following 217 
IPO compared to NPO but this did not quite reach significance (P =0.055) (Table 3). 218 
However, a paired T-test at the point of peak lipemia (4 h) showed that chylomicron 219 
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TAG was significantly lower after IPO compared to NPO (mean difference NPO-IPO 220 
0.463 mmol/L, 95% CI 0.032-0.894 mmol/L, P = 0.038). There were no differences in 221 
the TAG concentration of the IDL fraction, nor the cholesterol concentrations of the 222 
chylomicron and IDL fractions. Furthermore, no differences in IDL fraction 223 
apolipoprotein B48 concentrations were observed, although there was a large 224 
amount of inter-individual variability (table 3). The fatty acid composition of the 225 
plasma TAG fraction was close to the test meal fat composition at 4-5 h, the point of 226 
peak lipemia (Table 4). The proportion of plasma NEFA and TAG fractions that was 227 
16:0 increased (P <0.0005 and P <0.005 respectively) and the TAG fraction 18:1n-9 228 
proportion increased (P <0.005) following the meals, but the proportion of the NEFA 229 
fraction that was 18:1n-9 initially decreased at 1-2 h (P <0.005). Comparison 230 
between the test meals revealed that 16:0, 18:0, 18:1n-9 and 18:2n-6 profiles 231 
following NPO and IPO were similar.  232 
There were no significant meal effects or meal x time interactions for blood pressure 233 
or digital volume pulse (Supplementary Figure 1).  234 
DISCUSSION 235 
Evidence points to an independent role for non-fasting (postprandial) triglyceride 236 
concentrations as a risk factor for cardiovascular disease [20], and calculated non-237 
fasting remnant cholesterol concentrations have been associated with risk of 238 
coronary heart disease [21]. This study aimed to investigate whether the 239 
interesterification of palm olein resulted in adverse effects on postprandial lipemia in 240 
healthy men aged 40-70 y with higher than optimal fasting TAG concentrations. As 241 
previously reported in younger men and women [7, 10, 14], a blunted increase in 242 
plasma TAG during the early, pre-peak phase of postprandial lipemia was observed 243 
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following IPO compared to NPO. We decided to investigate an older, male 244 
population who had high-normal levels of fasting TAG and were likely to have a more 245 
pronounced postprandial lipemia [22], to confirm that the same response occurs in 246 
those who do not have overt cardiovascular disease or type 2 diabetes, but may 247 
have raised metabolic risk factors.  248 
Importantly, these results confirm that interesterification influences postprandial 249 
lipemic responses even in individuals with higher fasting TAG levels and a more 250 
pronounced lipemic response. The reduction in incremental AUC for plasma TAG 251 
during the early phase was in the order of 30%, which is considered clinically 252 
relevant. However, due to the lack of clinical prevention trials using standardized 253 
postprandial TAG measurements the implications of this size of reduction on risk of 254 
cardiovascular events is unknown. Furthermore the relative importance of the 255 
magnitude versus the duration of postprandial lipemia on cardiovascular risk is 256 
unknown. Quintiles of random measurements of non-fasting TAG concentrations that 257 
differed by a mean of ~0.3-0.5 mmol/L were associated with significantly increasing 258 
hazard ratios for coronary heart disease mortality in men from the Norwegian 259 
Counties Study, suggesting that postprandial differences of a similar size to that 260 
observed here could be clinically significant if these fats form a major component of 261 
a habitual high-fat diet [4]. The postprandial TAG response was approximately 1.5 262 
mmol/l higher at the 4 h peak concentration compared with our previous study [10], 263 
but it is also important to note that the total amount of fat was greater in the current 264 
study: 75 g compared to 50 g used previously [10]. A meal containing 75 g fat was 265 
administered because an objective of the study was to analyse the lipid composition 266 
of the chylomicron and IDL fractions, and by inducing a maximal increase in 267 
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postprandial TAG-rich lipoprotein (TRL), the detection of any meal-induced 268 
differences would be optimized.  269 
Prolonged lipemia is expected to result in compositional changes in lipid fractions 270 
due to the reciprocal exchange of TAG and cholesterol via CETP between 271 
chylomicron and HDL and LDL particles. It was hypothesised that although IPO 272 
might elicit a beneficial reduction in the early postprandial phase response (0-4 h) a 273 
subsequently prolonged postprandial lipemic response (> 4 h) would result in greater 274 
lipoprotein remodelling by CETP and therefore a higher remnant TAG concentration 275 
and greater TRL cholesterol content.  The cholesterol content of TAG-rich 276 
lipoproteins is thought to be an important causal factor in the development of 277 
atherosclerosis [23]. The concentration of TAG in the chylomicron fraction was 278 
moderately reduced 4-6 h following IPO compared to NPO, reflecting the reduction in 279 
total TAG concentration in plasma. This did not result in differences in the 280 
TAG:cholesterol ratio in the chylomicron and IDL fractions from 4-6 h. Furthermore, 281 
the IDL fraction apolipoprotein B-48 concentrations at 4-6 h did not appear to be 282 
affected by interesterification of palm olein, suggesting that clearance of chylomicron 283 
remnants is not improved nor impaired as a consequence of the reduced lipemia in 284 
the earlier postprandial phase. This agrees with our earlier study showing that total 285 
plasma apolipoprotein B48 concentrations did not differ over an 8 h postprandial 286 
period following 50 g IPO and NPO in younger men and women [10]. 287 
This observed difference in the postprandial lipemic response might be due to 288 
differences in the rate of intestinal absorption of the test fats. Palmitic acid profiles in 289 
the plasma TAG fraction and the proportions of palmitic acid in isolated chylomicron 290 
TAG fractions were similar following NPO and IPO as observed in our previous 291 
studies [7, 10], suggesting that both fats were absorbed at similar rates. However 292 
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this is inconclusive unless tracer-labelled palmitic acid is ingested, as total plasma 293 
TAG fraction palmitic acid also reflects VLDL palmitic acid and/ or chylomicron 294 
palmitic acid released from stored TAG within the enterocytes derived from a 295 
previous meal.  Evidence suggests that palmitic acid in the sn-2 position is unlikely to 296 
delay or reduce absorption in adults compared with TAG containing palmitic acid in 297 
the sn-1,3 positions [9]. It is therefore likely that the reduced lipemia observed 298 
following interesterification of palmitic acid-rich fats is due to changes in the physical 299 
characteristics of the fats, whereby the process of interesterification generates TAG 300 
species such as tri-palmitin and di-saturated TAG, which have melting points higher 301 
than body temperature. Indeed, in the current study the IPO contained a greater 302 
proportion of solid fat at 37 °C compared to NPO which was liquid at 37 °C and it is 303 
likely that the different melting points of the two test fats influenced the rate of 304 
digestion and absorption in the gut [5].  305 
A slower rate of absorption may have initially lowered the lipemic response but 306 
ultimately resulted in increased plasma TAG concentrations in the very late 307 
postprandial period, beyond the 6 h period monitored in the current study; this was 308 
observed by Sanders et al (2011), where plasma TAG concentrations remained at 309 
about 28% above fasting concentrations 8 h following IPO, compared to only about 310 
10% above fasting concentrations 8 h following NPO [10]. The duration of 311 
postprandial measurements is a limitation of the present study design as the effects 312 
on lipemia/TAG-rich lipoprotein composition beyond 6 h, and following subsequent 313 
meals, would further elucidate any differences as a result of interesterification of 314 
palm olein. Future studies should investigate compositional changes in the 315 
lipoprotein fractions at 8 and 10 h postprandially to achieve a better understanding of 316 
the influence of prolonged lipemia on the atherogenic potential of lipoproteins. 317 
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In summary, these compositional data from the lipoprotein fractions suggest that 318 
remnant triacylglycerol-rich lipoproteins are not differentially affected by palm oil 319 
interesterification up to 6 h, and imply that there is unlikely to be a greater risk of 320 
atherosclerosis when habitually consuming interesterified palm olein compared to 321 
native palm olein. However, further detailed investigations into lipoprotein fractions 322 
including the later postprandial phase (up to 8 or 10 h) and during chronic dietary 323 
interventions are required to confirm that compositional changes do not occur due to 324 
slower absorption and prolonged lipemia.  325 
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Fig. 1. CONSORT flow diagram. CONSORT, Consolidated Standards of Reporting Trials. 
Fig. 2 A Plasma and chylomicron fraction triacylglycerol (TAG) concentrations following 75 g native palm olein (closed 
symbols) and interesterified palm olein (open symbols). Mean with 95% CI, n = 11. Plasma TAG data were analysed by 
ANOVA on changes from fasting values: 1-6 h meal effect P = 0.067, meal x time interaction P = 0.469, and time effect P <0.0005; 
1-4 h meal effect P = 0.020, meal x time interaction P = 0.316, and time effect P <0.0005. Chylomicron fraction data were analysed 
by ANOVA on raw values: 4-6 h meal effect P = 0.055, meal x time interaction P = 0.147, and time effect P = 0.037. B Paired T-test 
of the iAUC 1-6 h for plasma TAG  showed a non-significant difference between meals (P = 0.090) but paired T-test of the iAUC 1-4 
h for plasma TAG showed a significant reduction following IPO compared to NPO (P = 0.024); error bars are 95% CI. C Plasma 
non-esterified fatty acids (NEFA) concentrations following 75 g native palm olein (closed symbols) and interesterified palm olein 
(open symbols). Mean with 95% CI, n = 10. Data were analyzed by ANOVA on changes from fasting values: meal effect P = 0.928, 
meal x time interaction P = 0.572 and time effect P < 0.0005. D Plasma cholesterol concentrations following 75 g native palm olein 
(closed symbols) and interesterified palm olein (open symbols). Mean with 95% CI, n = 11. Data were analyzed by ANOVA on 
changes from fasting values: meal effect P = 0.613, meal x time interaction P = 0.102 and time effect P = 0.001. 
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Table 1. Proportions of fatty acids in the total and sn-2 positions of the experimental 
test fats. 
Fatty acids (mol %) Native palm olein Interesterified palm olein 
    
12:0 Total 0.3 0.4 
 sn-2 0.0 0.0 
14:0 Total 1.1 1.2 
 sn-2 0.6 1.3 
16:0 Total 41.7 42.9 
 sn-2 9.8 45.9 
18:0 Total 4.2 4.5 
 sn-2 1.4 4.8 
16:1 Total 0.2 0.2 
 sn-2 0.3 0.3 
18:1n-9 Total 40.6 40.1 
 sn-2 68.4 38.9 
18:1n-7 Total 0.7 0.7 
 sn-2 0.0 0.0 
18:2n-6 Total 10.5 9.7 
 sn-2 19.6 8.7 
18:3n-3 Total 0.2 0.1 
 sn-2 0.0 0.1 
18:3n-6 Total 0.1 0.1 
 sn-2 0.0 0.0 
20:3n-6 Total 0.1 0.1 
 sn-2 0.0 0.0 
20:4n-6 Total 0.2 0.1 
 sn-2 0.0 0.0 
 
1 
 
Table 2. Characteristics of healthy male subjects who completed the study (n=11)a. 
Variable  
Age, y 50  7 
Body Mass Index, kg/m2 27.6  3.1 
Systolic blood pressure, mmHg 122.2  14.0 
Diastolic blood pressure, mmHg 80.1  10.2 
Waist circumference, cm 98.6  9.9 
Body Fat, % 26.3  5.6 
Fasting plasma glucose, mmol/L 5.6  0.3 
Fasting plasma triacylglycerol, mmol/L 1.8  0.3 
Fasting plasma total cholesterol, mmol/L  6.3  0.5 
Fasting plasma LDL cholesterol, mmol/L 4.1  0.5 
Fasting plasma HDL cholesterol, mmol/L 1.4  0.3 
aValues are means ± SD. 
1 
 
Table 3 Triacylglycerol and cholesterol composition of the chylomicron and IDL plasma lipoprotein fractions 4-6 h following 
consumption of meals containing 75 g native palm olein versus interesterified palm olein. 
 Native palm olein Interesterified palm olein P value  
(meal effect)  4h 5h 6h 4h 5h 6h 
TAG (mmol/L)        
Chylomicron fraction 1.43  
(1.08-1.79) 
1.25  
(0.95-1.55) 
1.04  
(0.84-1.24) 
0.97  
(0.70-1.24) 
1.03  
(0.78-1.28) 
0.85  
(0.63-1.06) 
0.055 
IDL fraction 1.89  
(1.33-2.44) 
1.70  
(1.40-2.00) 
1.70  
(1.38-2.01) 
1.87  
(1.54-2.21) 
1.84  
(1.63-2.04) 
1.76  
(1.55-1.98) 
0.693 
Cholesterol (mmol/L)        
Chylomicron fraction 0.36  
(0.26-0.46) 
0.37  
(0.30-0.45) 
0.32  
(0.24-0.39) 
0.32  
(0.22-0.42) 
0.35  
(0.25-0.44) 
0.29  
(0.18-0.40) 
0.498 
IDL fraction 1.26  
(0.85-1.67) 
1.26  
(0.88-1.64) 
1.26  
(0.85-1.67) 
1.57  
(1.12-2.03) 
1.66  
(1.11-2.22) 
1.47  
(0.99-1.95) 
0.229 
TAG/Cholesterol ratio        
Chylomicron fraction 4.03  
(3.55-4.51) 
3.36  
(2.72-4.00) 
3.41  
(2.88-3.95) 
3.22  
(2.75-3.69) 
3.11  
(2.71-3.51) 
3.43  
(2.53-4.33) 
0.268 
2 
 
IDL fraction 1.66  
(1.41-1.92) 
1.60  
(1.44-1.76) 
1.81  
(1.69-1.92) 
1.40  
(1.35-1.44) 
1.30  
(1.13-1.48) 
1.40  
(1.32-1.49) 
0.088 
Apo B48 in IDL fraction 
(ug/ml) ab 
15.02  
(2.62-27.42) 
15.42  
(7.00-23.84) 
17.89  
(9.72-26.05) 
17.94  
(4.81-31.07) 
19.10  
(7.08-31.13) 
17.20  
(3.48-30.93) 
0.405 
Values are means (95% confidence interval). a N=8 due to missing sample; all other data n=11. b Repeated ANOVA carried out on 
natural log transformed data. 
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Table 4. Proportions of fatty acids in plasma triacylglycerol and non-esterified fatty acid fractions 
during the 6 h postprandial period following consumption of meals containing 75 g native palm 
olein versus interesterified palm olein. 
Fatty acid (mol%) TAG fraction NEFA fraction 
 Native palm 
olein 
Interesterified 
palm olein 
Native palm 
olein 
Interesterified 
palm olein 
16:0  
 Baseline 
 1 h 
 2 h 
 3 h 
 4 h 
 5 h 
 6 h 
 
29.2 ± 3.5 
31.4 ± 5.2 
31.7 ± 4.3 
33.3 ± 2.6 
36.6 ± 8.7 
33.1 ± 3.0 
33.3 ± 4.1 
 
29.1 ± 2.6 
29.0 ± 2.3 
32.8 ± 6.5 
34.4 ± 9.4 
34.7 ± 4.7 
33.6 ± 4.7 
36.4 ± 11.4 
 
35.4 ± 10.4 
37.8 ± 13.2 
41.0 ± 14.9 
40.1 ± 12.5 
40.5 ± 12.4 
41.9 ± 13.7 
40.8 ± 13.1 
 
35.8 ± 10.2 
40.3 ± 13.4 
39.7 ± 10.5 
42.9 ± 13.5 
42.1 ± 12.1 
41.7 ± 12.5 
40.2 ± 14.2 
18:0  
Baseline 
1 h 
2 h 
3 h 
4 h 
5 h 
6 h 
 
3.3 ± 0.8 
3.5 ± 0.8 
4.1 ± 1.0 
3.6 ± 0.4 
3.7 ± 0.3 
4.1 ± 1.4 
3.3 ± 0.6 
 
3.1 ± 0.7 
3.2 ± 0.9 
3.6 ± 1.3 
3.8 ± 1.4 
3.4 ± 1.2  
3.7 ± 0.5 
4.0 ± 1.3 
 
10.5 ± 3.4 
9.7 ± 3.8 
8.8 ± 3.5 
8.2 ± 3.0 
8.2 ± 3.0 
8.4 ± 2.1 
8.4 ± 2.0 
 
9.5 ± 2.9 
9.5 ± 3.1 
9.1 ± 3.7 
8.4 ± 2.8 
7.6 ± 2.3 
8.1 ± 2.6 
8.8 ± 3.0 
18:1n-9 
Baseline 
 
32.6 ± 4.3 
 
30.3 ± 7.5 
 
22.2 ± 8.7 
 
20.3 ± 8.9 
2 
 
1 h 
2 h 
3 h 
4 h 
5 h 
6 h 
31.8 ± 8.5 
33.5 ± 3.3  
35.4 ± 2.7 
36.2 ± 3.5 
36.2 ± 3.0 
33.8 ± 8.0 
31.8 ± 8.3 
31.5 ± 8.4  
30.8 ± 8.5 
35.7 ± 2.7 
35.0 ± 3.2 
35.2 ± 1.8 
15.2 ± 8.5 
15.4 ± 10.0 
18.4 ± 9.2 
18.8 ± 9.4 
20.7 ± 9.7 
21.4 ± 9.0 
16.3 ± 8.9 
15.9 ± 8.7 
16.8 ± 10.8 
19.9 ± 9.3 
20.6 ± 9.7 
17.6 ± 9.2 
18:2n-6 
Baseline 
1 h 
2 h 
3 h 
4 h 
5 h 
6 h 
 
11.4 ± 1.4 
12.0 ± 1.8 
10.7 ± 2.5 
11.2 ± 1.4 
10.8 ± 1.2 
10.8 ± 1.2 
11.1 ± 1.7 
 
10.8 ± 2.3 
11.7 ± 2.2 
10.0 ± 2.7 
9.3 ± 3.0 
10.2 ± 1.1 
10.1 ± 1.8 
10.1 ±1.3 
 
7.0 ± 3.5 
5.8 ± 4.6 
6.5 ± 5.9 
6.8 ± 3.0 
6.6 ± 5.3 
6.0 ± 2.7 
6.8 ± 2.8 
 
6.4 ± 2.6 
5.4 ± 2.6 
5.9 ± 3.2 
5.3 ± 3.2 
6.2 ± 3.0 
6.0 ± 2.8 
5.6 ± 3.3 
 
Data are means ±SD. N=10, except for TAG 18:1n-9 and TAG 18:2n-6 where N=9. 
There were no meal effects or meal x time interactions for the compositions (mol %) of 16:0 
(palmitic acid), 18:0 (stearic acid), 18:1n-9 (oleic acid), and 18:2n-6 (linoleic acid) in plasma 
TAG and NEFA fractions during the postprandial period. Time effects: there were significant 
increases in TAG 16:0, P <0.005; NEFA 16:0, P <0.0005; TAG 18:1n-9, P <0.005; and 
significant decreases in NEFA 18:0, P <0.005; TAG 18:2n-6, P <0.05; and an initial sharp 
decrease 1-2 h in NEFA 18:1n-9, followed by a return to baseline levels 3-6 h, P <0.005. There 
were no time effects for plasma TAG fraction 18:0 mol % composition, nor plasma NEFA 
fraction 18:2n-6.  
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Supplementary Figure 1. 
Vascular function and blood pressure following 75 g native palm olein (closed symbols) and 
interesterified palm olein (open symbols). Mean with 95% CI, n = 11. Data were analyzed by ANOVA 
on changes from fasting values. A Digital volume pulse stiffness index (DVP-SI): meal effect P = 0.447, 
meal x time interaction P = 0.342, and time effect P = 0.711. B Digital volume pulse reflection index 
(DVP-RI): meal effect P = 0.872, meal x time interaction P = 0.474, and time effect P = 0.002.  C 
Systolic blood pressure (SBP): meal effect P = 0.433, meal x time interaction P = 0.015 and time 
effect P < 0.0005. D Diastolic blood pressure (DBP): meal effect P = 0.496, meal x time interaction P = 
0.706 and time effect P < 0.0005. 
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